MARKSANS PHARMA LTD. (MARKSANS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 485.98 500.03 531.24 586.13 560.01 590.62 641.92 681.85 70.85 619.99 720.41 754.43
YOY Revenue Growth % 16.25% 15.28% 17.38% 22.15% 15.23% 18.12% 20.84% 16.33% -87.35% 4.97% 12.23% 10.64%
Other Income 11.01 10.10 19.00 4.80 16.53 14.95 11.06 27.85 1.65 5.64 21.57 20.14
Total Income 496.99 510.13 550.23 590.93 576.54 605.57 652.98 709.70 72.50 625.63 741.98 774.57
Total Expenses + 244.79 307.06 339.27 373.16 328.92 361.71 462.23 434.00 60.89 549.03 608.65 623.95
Cost of Materials Consumed 112.20 151.76 174.70 192.87 148.38 161.31 214.39 189.26 18.81 192.69 227.72 273.82
Employee Benefit Expense 60.89 68.24 71.13 74.53 79.75 80.48 84.16 88.44 9.72 98.39 103.80 111.99
Other Expenses 71.70 87.07 93.44 105.76 100.80 119.92 163.69 156.30 16.03 159.67 163.52 165.47
Operating Profit 241.19 192.97 191.97 212.97 231.09 228.91 179.70 247.85 9.96 70.96 111.76 130.48
OPM % 49.6% 38.6% 36.1% 36.3% 41.3% 38.8% 28% 36.3% 14.1% 11.4% 15.5% 17.3%
Profit Before Tax + 104.17 96.83 113.77 112.66 100.28 120.02 124.60 143.26 11.61 76.60 133.33 150.62
Tax Expense 21.46 26.39 29.92 29.69 22.63 30.95 26.84 38.19 2.54 18.40 34.20 36.93
Tax % 20.6% 27.3% 26.3% 26.4% 22.6% 25.8% 21.5% 26.7% 21.9% 24% 25.6% 24.5%
Profit After Tax 82.71 70.44 83.85 82.97 77.64 89.07 97.76 105.07 9.07 58.20 99.14 113.69
EPS (Basic) 1.97 1.52 1.84 1.84 1.73 1.96 2.13 2.31 2.00 1.29 2.17 2.50

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 262.28 2,177.41 1,852.14 1,490.84 1,376.18 1,134.21 1,000.07
YOY Revenue Growth % -87.95% 17.56% 24.23% 8.33% 21.33% 13.41% -
Other Income 7.04 50.42 59.31 41.85 6.69 0.33 4.62
Total Income 269.32 2,227.83 1,911.45 1,532.69 1,382.88 1,134.54 1,004.69
Total Expenses + 218.93 1,348.41 1,204.43 1,055.81 861.28 768.41 781.98
Cost of Materials Consumed 75.30 667.70 612.97 540.67 419.76 371.33 412.06
Employee Benefit Expense 35.03 293.64 239.37 220.30 197.32 168.42 159.07
Other Expenses 60.02 387.07 352.09 294.84 244.20 228.66 210.85
Operating Profit 43.36 829.00 647.71 435.03 514.90 365.80 218.09
OPM % 16.5% 38.1% 35% 29.2% 37.4% 32.3% 21.8%
Profit Before Exceptional 50.40 423.53 337.65 247.51 302.16 157.17 104.31
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 50.40 423.53 337.65 247.51 302.16 157.17 104.31
Tax Expense 12.13 108.63 72.33 60.70 63.63 36.42 23.87
Tax % 24.1% 25.6% 21.4% 24.5% 21.1% 23.2% 22.9%
Profit After Tax 38.26 314.90 265.32 186.81 238.54 120.75 80.44
EPS (Basic) 8.40 6.92 6.41 4.51 5.76 2.86 1.87

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 103.55 818.46 515.09 0.00 0.00 0.00 0.00
Property, Plant & Equipment 57.95 675.71 379.64 0.00 0.00 0.00 0.00
Capital Work in Progress 0.90 5.38 7.25 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 4.09 39.50 38.49 0.00 0.00 0.00 0.00
Other Intangible Assets 36.16 60.73 68.17 0.00 0.00 0.00 0.00
Current Assets + 220.41 1,862.49 1,675.30 0.00 0.00 0.00 0.00
Inventories 84.55 617.94 484.74 0.00 0.00 0.00 0.00
Trade Receivables 54.00 453.18 416.85 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 49.58 403.28 382.44 0.00 0.00 0.00 0.00
Current Investments 0.07 26.99 0.54 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 4.53 45.32 45.32 0.00 0.00 0.00 0.00
Other Equity 242.16 2,019.74 1,699.85 0.00 0.00 0.00 0.00
Non-Current Liabilities 27.29 205.20 84.33 0.00 0.00 0.00 0.00
Current Liabilities 47.73 389.85 340.99 0.00 0.00 0.00 0.00
Total Liabilities 75.03 595.05 425.32 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 20.67 230.41 237.41 99.26 0.00 0.00 0.00
Cash from Investing Activities -4.90 -140.84 -259.21 -41.69 0.00 0.00 0.00
Cash from Financing Activities -6.51 -68.73 197.83 79.51 0.00 0.00 0.00
Net Increase/Decrease in Cash 9.25 20.84 176.03 137.08 0.00 0.00 0.00